Project: AD Scanner for Prognosis of Alzheimer’s Disease by Blood Analysis
| Acronym | AD SCANNER (Reference Number: 12765) |
| Duration | 25/02/2019 - 26/02/2021 |
| Project Topic | The main outcome is a novel, fast (<1 h) and inexpensive (<10 € per sample) blood assay for assessing the Alzheimer's disease (AD) progression rate or even risk of developing AD. The main goal is to create a novel analytical device, the AD Scanner, for measuring the level of protein biomarkers (abnormal proteoforms) in human blood plasma, serum or cerebrospinal fluid around the isoelectric point (pI) ˜7.35. The AD Scanner will be highly valuable in both pre-clinical research and the hospital lab |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 10 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Biomotif AB | Coordinator | Sweden |
| 2 | Karolinska Institutet | Partner | Sweden |
| 3 | Spectrometry Vision BV | Partner | Netherlands |
| 4 | Paraytec Ltd | Partner | United Kingdom |
| 5 | VUMC | Partner | Netherlands |